A nurse is developing a plan of care for a client who has Meniere’s disease. Which of the following medications should the nurse anticipate administering?
Pantoprazole
Warfarin
Furosemide
Oxybutynin
The Correct Answer is C
Pantoprazole: Pantoprazole is a proton pump inhibitor commonly used to reduce stomach acid production. It is primarily indicated for the treatment of gastroesophageal reflux disease (GERD), peptic ulcers, and other conditions related to excessive stomach acid production. It does not play a role in managing Meniere's disease, which is a disorder of the inner ear characterized by episodes of vertigo, tinnitus, and hearing loss.
B) Warfarin: Warfarin is an anticoagulant medication used to prevent blood clot formation. It is commonly prescribed for conditions such as atrial fibrillation, deep vein thrombosis, and pulmonary embolism. Meniere's disease does not typically require anticoagulant therapy, so warfarin would not be indicated for its treatment.
C) Furosemide: Furosemide is a loop diuretic that helps reduce fluid retention by increasing urine output. In some cases of Meniere's disease, especially those associated with excessive endolymphatic fluid buildup in the inner ear, furosemide may be prescribed to help reduce fluid volume and alleviate symptoms such as vertigo and pressure sensation in the ear.
D) Oxybutynin: Oxybutynin is an anticholinergic medication primarily used to treat overactive bladder and urinary incontinence. It works by relaxing smooth muscle in the bladder, reducing bladder spasms and urinary urgency. While some individuals with Meniere's disease may experience associated symptoms such as frequent urination or urinary urgency, oxybutynin is not a standard treatment for Meniere's disease itself.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
A. "Your heart condition is caused by excessive stretching of the ventricles": This statement is incorrect. Excessive stretching of the ventricles typically occurs in dilated cardiomyopathy, not restrictive cardiomyopathy (RCM). In RCM, the primary issue is not excessive stretching but rather stiffening of the ventricular walls.
B. "Your heart condition is caused from stiffening of the walls of the ventricles": This statement is correct. Restrictive cardiomyopathy (RCM) is characterized by abnormal stiffening (fibrosis) of the ventricular walls, which impairs the heart's ability to fill properly during the diastolic phase of the cardiac cycle. This stiffening restricts the heart's ability to relax and fill with blood efficiently.
C. "Your heart condition is caused by thickening of the ventricular walls and septum": This statement describes hypertrophic cardiomyopathy (HCM), not restrictive cardiomyopathy (RCM). In HCM, there is abnormal thickening of the ventricular walls and septum, leading to impaired filling of the ventricles and potential obstruction of blood flow out of the heart.
D. "Your heart condition is caused when the ventricular tissue becomes fibrous and fatty": This statement describes arrhythmogenic right ventricular cardiomyopathy (ARVC), not restrictive cardiomyopathy (RCM). ARVC is characterized by replacement of myocardial tissue with fibrous and fatty tissue, primarily affecting the right ventricle.
Correct Answer is D
Explanation
A) "Pentoxifylline can be administered to help the platelets from sticking together and occluding the vessels": Pentoxifylline is a medication used to improve blood flow by decreasing the viscosity of blood. However, it is not typically used to treat mitral valve stenosis. This statement does not accurately reflect treatment options for this condition.
B) "A heparin bolus is administered and followed with a continuous infusion to help keep the blood thinner": Heparin is an anticoagulant used to prevent blood clot formation, but it is not a treatment for mitral valve stenosis itself. While anticoagulants may be used in certain situations with mitral valve stenosis (such as in the setting of atrial fibrillation), they do not directly address the underlying valve narrowing.
C) "A flexible catheter will be inserted into a vessel of the arm, neck, or groin and advanced to the heart to dilate a narrowed or occluded artery": This statement describes a procedure known as percutaneous transluminal mitral valvuloplasty (PTMV), which is a minimally invasive intervention used to treat mitral valve stenosis. During this procedure, a catheter with a deflated balloon on its tip is inserted into a vessel and guided to the heart, where the balloon is inflated to widen the narrowed valve.
D) "A small catheter with a balloon on the end is threaded into a vessel in the groin and advanced to the heart where the balloon will be inflated, and the narrowed valve will be dilated": This statement accurately describes balloon valvuloplasty, which is a common procedure used to treat mitral valve stenosis. By inflating the balloon within the narrowed valve, the procedure aims to widen the valve opening, thus improving blood flow through the heart.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.